§ 2.36 - xxx


Latest version.
  • Link to an amendment published at

    § 2.36 xxx

    Cross Reference

    Disclosures to prescription drug monitoring programs.

    A part 2 program or other lawful holder is permitted to report any SUD medication prescribed or dispensed by the part 2 program to the applicable state prescription drug monitoring program if required by applicable state law. A part 2 program or other lawful holder must obtain patient consent to a disclosure of records to a prescription drug monitoring program under § 2.31 prior to reporting of such information.

    [85 FR 43038, July 15, 2020

    .

    ]